期刊文献+

老药新用研究策略与应用(2)——基于新适应证发现的研究策略与应用

Drug Repurposing(2):Strategies and Applications on Discovering New Indications
下载PDF
导出
摘要 近年来,“老药新用”概念被用于许多临床上正用于治疗疾病的药物,以及曾经或正处于临床前或临床试验中的候选药物。历史上及当前一系列著名的药物重定位应用,推动了基于“老药新用”的药物研发,并使之应用于新的适应证。该文基于新适应证的发现,论述新药研究中药物重定位,讨论了一系列新适应证的“老药新用”的科学研究基础及关键研究策略,包括根据药物现有基本作用机制发现新适应证,根据药物副作用发现新适应证,以及基于药物新作用机制发现新适应证等。 In recent years,many clinically applied drugs,as well as drug candidates that had been or were in preclinical or clinical trials,had been redeveloped for new indications.The success of repurposing of a series of famous drugs had promoted the repurposing developments.In the previous article,the drug repurposing study based on clinical treatment needs had been discussed.In this paper,we reviewed drug repurposing studies based on the discovery of new indications.We reviewed repurposing strategies,including the discovery of new indications based on the existing basic action mechanism of drugs,the discovery of new indications based on the side effects of drugs,and the discovery of new indications based on the new action mechanism of drugs.
作者 杜立达 范晓诺 宋俊科 张丽 张雯 谢逸菲 吕扬 DU Lida;FAN Xiaonuo;SONG Junke;ZHANG Li;ZHANG Wen;XIE Yifei;LYU Yang(De-partment of Surgery,Uniersity of Toronto,Toronto,ON,Canada M5S 148;Department of Biology,Boston U-niversity,Boston,MA 02215;Beyjing Key Laboratory of Drug Target Ildentification and Drug Screening,Beijing 100050,China;Institute of Materia Medica,Chinese Academy of Medical Sciences and Peking Union Medical College,Bejing,100050,China;Bejing Key Laboratory of Polymorphic Drugs,Bejing 100050,China)
出处 《医药导报》 CAS 北大核心 2023年第3期299-303,共5页 Herald of Medicine
基金 国家重点研发计划(2020YFC2008302) 国家自然科学基金资助项目(82141204) 中国医学科学院医学与健康科技创新工程重大协同创新项目(2021-I2M-1-005)。
关键词 老药新用 药物发现 新适应证 Drug repurposing Drug discovery New indications
  • 相关文献

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部